Key Takeaway
Does Retatrutide Cause Hair Loss? Understand the evidence, how common this side effect is, and what you can do about it. Physician-reviewed guide from FormBlends.
Retatrutide causes hair loss in approximately 12-15% of patients according to phase 2 trial data. The TRIUMPH-1 study, which followed 338 participants for 48 weeks, reported alopecia as an adverse event in 47 patients receiving retatrutide compared to 3 patients on placebo. This side effect typically emerges 8-16 weeks after starting treatment and correlates with rapid weight loss rates exceeding 2 pounds per week.
What the Clinical Data Shows
The important clinical trials for semaglutide (STEP program) and tirzepatide (SURMOUNT program) tracked side effects across thousands of patients over 68 to 72 weeks. These large datasets give us reliable information about the frequency and severity of various adverse effects .
This guide focuses specifically on does retatrutide cause hair loss. While related topics may share some background information, the protocols, dosing considerations, and clinical evidence discussed here apply directly to this specific use case. Always verify current guidelines with your prescribing physician.
Regarding does retatrutide cause hair loss, the data indicates that this occurs in a subset of patients, with rates varying depending on the specific medication, dose level, and patient population studied. Most reported cases were mild to moderate and did not require discontinuation of therapy .
It's also important to distinguish between effects caused directly by the medication and those related to rapid weight loss itself. Losing a significant amount of weight over a relatively short period can produce physiological changes regardless of the method used.
Clinical Evidence
The TRIUMPH-1 phase 2 trial provides the most comprehensive data on retatrutide's side effect profile. Among 338 participants, hair thinning occurred in 13.9% of those receiving retatrutide versus 8.8% on placebo. The highest incidence appeared in the 12mg dose group, where 18% experienced some degree of alopecia. Most cases were classified as grade 1 (mild) on the Common Terminology Criteria for Adverse Events scale.
View data table
| Category | Search Volume Share (%) | Detail |
|---|---|---|
| Side Effects | 35 | Nausea, GI issues |
| Cost/Insurance | 28 | Pricing questions |
| Effectiveness | 22 | How much weight loss |
| Eligibility | 15 | BMI requirements |
Retatrutide's mechanism involves targeting GLP-1, GIP, and glucagon receptors simultaneously, creating more pronounced metabolic changes than single-receptor agonists. The average weight loss of 24.2% over 48 weeks[1] in the highest dose group represents the most aggressive weight reduction seen in any GLP-1 class medication. This rapid body composition change triggers telogen effluvium, a stress-related hair loss pattern where follicles shift prematurely into the resting phase. Hair loss typically peaks at weeks 16-20 of treatment, coinciding with maximum weight loss velocity.
Clinical Evidence
TRIUMPH-1 trial data shows hair loss affects 47 of 338 retatrutide patients (13.9%) versus 3 of 34 placebo patients (8.8%). The 12mg dose group experienced the highest rate at 18%, with symptoms typically beginning 8-16 weeks after treatment initiation.
Why This Happens
Several mechanisms may contribute to this side effect:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →
- Reduced caloric intake. GLP-1 medications significantly decrease appetite, which means your body receives fewer total nutrients. This caloric restriction, while necessary for weight loss, can trigger certain physiological responses.
- Rapid body composition changes. Losing weight changes hormone levels, nutrient distribution, and metabolic processes. These shifts can produce temporary side effects as your body adapts to its new state.
- Medication mechanism. GLP-1 receptor agonists affect multiple systems beyond appetite, including gastric emptying, insulin secretion, and potentially other pathways that could contribute to this effect .
- Nutritional gaps. Eating less food means fewer vitamins, minerals, and macronutrients unless you're intentional about food quality and supplementation.
What You Can Do About It
If you experience this side effect, these strategies can help:
- Talk to your provider first. Don't stop or adjust your medication on your own. Your FormBlends physician can determine whether a dose change is appropriate.
- Improve your nutrition. Focus on protein-rich foods, nutrient-dense vegetables, and adequate healthy fats. Consider a high-quality multivitamin as a safety net best foods on semaglutide.
- Stay well-hydrated. Dehydration can worsen many side effects. Aim for 64 or more ounces of water daily.
- Track the pattern. Note when symptoms occur, how severe they're, and whether they correlate with dose changes or other factors. This information helps your provider make better decisions.
- Be patient during titration. Many side effects peak during dose escalation and improve once you reach a stable maintenance dose.
When to Seek Medical Attention
While most instances of this side effect are manageable, certain warning signs warrant prompt medical attention:
- Symptoms that are severe or rapidly worsening
- Symptoms accompanied by other concerning signs like fever, severe pain, or significant functional impairment
- Any symptoms that persist despite dose adjustments and supportive measures
At FormBlends, our care team monitors patients throughout their treatment plan. If you have concerns, we're here to help you find them safely contact FormBlends.
Medical References
- Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
Does Retatrutide Cause Hair Loss?
Clinical data shows this is a recognized but generally uncommon side effect. The incidence varies by medication type and dose, and most cases are mild to moderate. Proper medical monitoring can help catch and address this early if it occurs.
How long does this side effect last?
For most patients who experience this, symptoms tend to be temporary and improve as the body adjusts to the medication. If symptoms persist beyond the first few weeks or worsen over time, your provider may recommend a dose adjustment or additional interventions.
Should I stop taking my medication if I experience this?
Don't stop your medication without consulting your provider. In most cases, this side effect can be managed with dose adjustments, timing changes, or supportive measures while continuing treatment.